EUCTR2005-002342-19-CZ进行中（未招募）不适用
A multicentre, open label study to evaluate the safety and efficacy of Alendros 70 therapy administered 70mg once a week in women with postmenopausal osteoporosis
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •ambulatory,
- •age to 80 years
- •Postmenopausal osteoporosis
- •Meets the BMD criteria of the lumbar spine or proximal femur for osteoporosis
- •Are the trial subjects under 18?
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.have evidence of a clinically significant psychiatric or organic disease which could prevent the patient from completing the study
- •2.abuse of alcohol or use illicit drugs
- •3.any allergic or abnormal reaction to bisphosphonates
- •4. hypokalcemia
- •5. serious disease of the gastrointestinal tract
- •6. inability be seated for 30 minutes
研究者
相似试验
进行中（未招募）
1 期
Safety and tolerability of higher infusion parameters of IgPro20 (Hizentra) in subjects with primary immunodeficiency (PID)EUCTR2016-003799-33-Outside-EU/EEACSL Behring LLC51
进行中（未招募）
不适用
A research study to look at the safety, effectiveness and the effects on the body of a new drug, SBC-102, in adults with liver problems caused by a deficiency in the enzyme that breaks down fats.EUCTR2010-024068-16-CZSynageva Biopharma Corp.9
进行中（未招募）
不适用
SBC-102 in patients with liver dysfunction due to LAL deficiencyEUCTR2010-024068-16-GBSynageva Biopharma Corp.9
进行中（未招募）
1 期
Safety and diagnostic Efficacy of Mangoral in Patients with abnormal liver cells and reduced kidney functioMRI in terms of visualization of detected focal liver lesions in patients with known or Suspected focal liver lesions and severe renal impairmentMedDRA version: 22.1Level: LLTClassification code 10028049Term: MRISystem Organ Class: 100000004848EUCTR2019-001599-12-ITAscelia Pharma AB197
进行中（未招募）
1 期
A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients with Known or Suspected Focal Liver Lesions and Severe Renal ImpairmentEUCTR2019-001599-12-SEAscelia Pharma AB197